REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

I2 Medisience Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: I2 Medisience Sp. z o.o. Profile Updated: May 13, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

I2 Medisience Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on April 21, 2021. From the latest financial highlights, I2 Medisience Sp. z o.o. reported a net sales revenue increase of 259.69% in 2022. Its’ total assets recorded a growth of 50.07%. The net profit margin of I2 Medisience Sp. z o.o. decreased by 3.97% in 2022.

Headquarters
Ul. Panska 96 83
Warsaw; Mazowieckie; Postal Code: 00-837

Contact Details: Purchase the I2 Medisience Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the I2 Medisience Sp. z o.o. report to view the information.
Registered Capital:
Purchase the I2 Medisience Sp. z o.o. report to view the information.
Incorporation Date:
April 21, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after I2 Medisience Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
259.69%▲
Total operating revenue
262.92%▲
Operating profit (EBIT)
196.89%▲
Net Profit (Loss) for the Period
185.92%▲
Total assets
50.07%▲
Total equity
272.46%▲
Operating Profit Margin (ROS)
-3.58%▼
Net Profit Margin
-3.97%▼
Return on Equity (ROE)
-22.14%▼
Quick Ratio
0.99%▲
Cash Ratio
0.13%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo